Apollo Endosurgery, Inc.
- Jurisdiction
United States - LEI
549300OD82W5UIMD4H13 - ISIN
US03767D1081 (APEN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Read full profile
Stock price
Fundamentals
- Net revenue
€65.94M - Gross margin
55.2% - EBIT
-€23.87M - EBIT margin
-36.2% - Net income
-€34.18M - Net margin
-51.8%
Statement period: - (published )
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: November 1, 2022